Brief: Orthocell Submits Thailand Regulatory Application To Commence Sales Of Remplir
21/02/2025 01:04
Feb 21 (Reuters) - Orthocell Ltd OCC.AX :
* SUBMITS THAILAND REGULATORY APPLICATION TO COMMENCE SALES
OF
REMPLIR INTO US$84MILLION THAI MARKET
Further company coverage: OCC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense